UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="Sobril-10mg-Tablet-SE-IS-MPD-BBDL"/>
<type value="collection"/>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
<resource>
<MedicinalProductDefinition>
<id value="Sobril-10mg-Tablet-SE-IS-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_Sobril-10mg-Tablet-SE-IS-MPD"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Sobril-10mg-Tablet-SE-IS-MPD</b></p><a name="Sobril-10mg-Tablet-SE-IS-MPD"> </a><a name="hcSobril-10mg-Tablet-SE-IS-MPD"> </a><a name="hcSobril-10mg-Tablet-SE-IS-MPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100001390-00008880, <code>http://ema.europa.eu/fhir/eurdId</code>/2234</p><p><b>domain</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human use</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}">Tablet</span></p><p><b>indication</b>: </p><div><p>Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072085}">Medicinal product subject to special medical prescription</span></p><p><b>classification</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000116677 100000093533}">N05BA04</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Sobril® 10 mg Tablett</p><blockquote><p><b>part</b></p><p><b>part</b>: Sobril®</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 10 mg</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Tablett</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{urn:ietf:bcp:47 sv}">Swedish</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="SE-100001390-00008880"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/eurdId"/>
<value value="2234"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</combinedPharmaceuticalDoseForm>
<indication
value="Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk."/>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="100000072085"/>
<display
value="Medicinal product subject to special medical prescription"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000116677"/>
<code value="100000093533"/>
<display value="N05BA04"/>
</coding>
</classification>
<name>
<productName value="Sobril® 10 mg Tablett"/>
<part>
<part value="Sobril®"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented name part"/>
</coding>
</type>
</part>
<part>
<part value="10 mg"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="Tablett"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="sv"/>
<display value="Swedish"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/Sobril-10mg-Tablet-SE-IS-RA"/>
<resource>
<RegulatedAuthorization>
<id value="Sobril-10mg-Tablet-SE-IS-RA"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_Sobril-10mg-Tablet-SE-IS-RA"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization Sobril-10mg-Tablet-SE-IS-RA</b></p><a name="Sobril-10mg-Tablet-SE-IS-RA"> </a><a name="hcSobril-10mg-Tablet-SE-IS-RA"> </a><a name="hcSobril-10mg-Tablet-SE-IS-RA-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/8880</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}">Valid</span></p><p><b>statusDate</b>: 1973-12-14</p><p><b>holder</b>: <a href="Organization-LOC-100005188.html">Organization Pfizer AB</a></p><h3>Cases</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}">First Authorisation</span></td><td>1973-12-14</td></tr></table></div>
</text>
<identifier>
<system
value="http://ema.europa.eu/fhir/marketingAuthorizationNumber"/>
<value value="8880"/>
</identifier>
<subject>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000060"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</region>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072049"/>
<code value="100000072099"/>
<display value="Valid"/>
</coding>
</status>
<statusDate value="1973-12-14"/>
<holder>🔗
<reference value="Organization/LOC-100005188"/>
</holder>
<case>
<type>
<coding>
<system
value="https://ema.europa.eu/fhir/authorisationDateType"/>
<code value="dateOfFirstAuthorisation"/>
<display value="First Authorisation"/>
</coding>
</type>
<dateDateTime value="1973-12-14"/>
</case>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Sobril-10mg-Tablet-SE-IS-PPD01"/>
<resource>
<PackagedProductDefinition>
<id value="Sobril-10mg-Tablet-SE-IS-PPD01"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_Sobril-10mg-Tablet-SE-IS-PPD01"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition Sobril-10mg-Tablet-SE-IS-PPD01</b></p><a name="Sobril-10mg-Tablet-SE-IS-PPD01"> </a><a name="hcSobril-10mg-Tablet-SE-IS-PPD01"> </a><a name="hcSobril-10mg-Tablet-SE-IS-PPD01-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></p><p><b>containedItemQuantity</b>: 10 Tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Blister, 100 tabletter</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="10"/>
<unit value="Tablet"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</containedItemQuantity>
<description value="Blister, 100 tabletter"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="10"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003208"/>
<display value="Plastic"/>
</coding>
</material>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003200"/>
<display value="Aluminium"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</reference>
</item>
<amount>
<value value="10"/>
<unit value="Tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</amount>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Sobril-10mg-Tablet-SE-IS-PPD02"/>
<resource>
<PackagedProductDefinition>
<id value="Sobril-10mg-Tablet-SE-IS-PPD02"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_Sobril-10mg-Tablet-SE-IS-PPD02"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition Sobril-10mg-Tablet-SE-IS-PPD02</b></p><a name="Sobril-10mg-Tablet-SE-IS-PPD02"> </a><a name="hcSobril-10mg-Tablet-SE-IS-PPD02"> </a><a name="hcSobril-10mg-Tablet-SE-IS-PPD02-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></p><p><b>containedItemQuantity</b>: 5 Tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Blister, 25 tabletter</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="5"/>
<unit value="Tablet"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</containedItemQuantity>
<description value="Blister, 25 tabletter"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="5"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003208"/>
<display value="Plastic"/>
</coding>
</material>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003200"/>
<display value="Aluminium"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</reference>
</item>
<amount>
<value value="5"/>
<unit value="Tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</amount>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Sobril-10mg-Tablet-SE-IS-PPD03"/>
<resource>
<PackagedProductDefinition>
<id value="Sobril-10mg-Tablet-SE-IS-PPD03"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_Sobril-10mg-Tablet-SE-IS-PPD03"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition Sobril-10mg-Tablet-SE-IS-PPD03</b></p><a name="Sobril-10mg-Tablet-SE-IS-PPD03"> </a><a name="hcSobril-10mg-Tablet-SE-IS-PPD03"> </a><a name="hcSobril-10mg-Tablet-SE-IS-PPD03-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></p><p><b>containedItemQuantity</b>: 1 Tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Blister, 49 x 1 tablett (endos)</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="1"/>
<unit value="Tablet"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</containedItemQuantity>
<description value="Blister, 49 x 1 tablett (endos)"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000174066"/>
<display value="Unit-dose blister"/>
</coding>
</type>
<quantity value="49"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003208"/>
<display value="Plastic"/>
</coding>
</material>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003200"/>
<display value="Aluminium"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</reference>
</item>
<amount>
<value value="1"/>
<unit value="Tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</amount>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
<resource>
<ManufacturedItemDefinition>
<id value="Sobril-10mg-Tablet-SE-IS-MID"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_Sobril-10mg-Tablet-SE-IS-MID"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition Sobril-10mg-Tablet-SE-IS-MID</b></p><a name="Sobril-10mg-Tablet-SE-IS-MID"> </a><a name="hcSobril-10mg-Tablet-SE-IS-MID"> </a><a name="hcSobril-10mg-Tablet-SE-IS-MID-en-US"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}">Tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002152}">Tablet</span></p></div>
</text>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING01"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING01"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING01"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING01</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING01"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING01"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING01-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091921}">Oxazepam</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 10 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 unit(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110756 = '100000110756')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091921}">Oxazepam</span></td></tr></table><p><b>strength</b>: 10 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 unit(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110756 = '100000110756')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091921"/>
<display value="Oxazepam"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="10"/>
<unit value="milligram(s)"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="unit(s)"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110756"/>
</denominator>
</presentationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091921"/>
<display value="Oxazepam"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="10"/>
<unit value="milligram(s)"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="unit(s)"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110756"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING02"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING02"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING02"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING02</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING02"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING02"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING02-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092393}">Calcium hydrogen phosphate dihydrate</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000092393"/>
<display value="Calcium hydrogen phosphate dihydrate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING03"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING03"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING03"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING03</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING03"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING03"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING03-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000078231}">Cellulose, microcrystalline</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000078231"/>
<display value="Cellulose, microcrystalline"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING04"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING04"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING04"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING04</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING04"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING04"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING04-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000088586}">Magnesium stearate</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000088586"/>
<display value="Magnesium stearate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING05"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING05"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING05"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING05</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING05"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING05"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING05-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092381}">Povidone</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000092381"/>
<display value="Povidone"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING06"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING06"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING06"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING06</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING06"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING06"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING06-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092242}">Silica, colloidal anhydrous</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000092242"/>
<display value="Silica, colloidal anhydrous"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING07"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING07"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING07"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING07</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING07"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING07"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING07-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000135889}">Sodium laurilsulfate</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000135889"/>
<display value="Sodium laurilsulfate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING08"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING08"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING08"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING08</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING08"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING08"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING08-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000086041}">Sodium starch glycolate</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000086041"/>
<display value="Sodium starch glycolate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Sobril-10mg-Tablet-SE-IS-ING09"/>
<resource>
<Ingredient>
<id value="Sobril-10mg-Tablet-SE-IS-ING09"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Sobril-10mg-Tablet-SE-IS-ING09"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Sobril-10mg-Tablet-SE-IS-ING09</b></p><a name="Sobril-10mg-Tablet-SE-IS-ING09"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING09"> </a><a name="hcSobril-10mg-Tablet-SE-IS-ING09-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></li><li><a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Sobril-10mg-Tablet-SE-IS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000079044}">Wheat starch</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000079044"/>
<display value="Wheat starch"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/AdministrableProductDefinition/Sobril-10mg-Tablet-SE-IS-APD"/>
<resource>
<AdministrableProductDefinition>
<id value="Sobril-10mg-Tablet-SE-IS-APD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_Sobril-10mg-Tablet-SE-IS-APD"> </a><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition Sobril-10mg-Tablet-SE-IS-APD</b></p><a name="Sobril-10mg-Tablet-SE-IS-APD"> </a><a name="hcSobril-10mg-Tablet-SE-IS-APD"> </a><a name="hcSobril-10mg-Tablet-SE-IS-APD-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Sobril-10mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00008880,http://ema.europa.eu/fhir/eurdId#2234; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA04</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}">Tablet</span></p><p><b>producedFrom</b>: <a href="ManufacturedItemDefinition-Sobril-10mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}">Oral use</span></td></tr></table></div>
</text>
<status value="active"/>
<formOf>🔗
<reference
value="MedicinalProductDefinition/Sobril-10mg-Tablet-SE-IS-MPD"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</administrableDoseForm>
<producedFrom>🔗
<reference
value="ManufacturedItemDefinition/Sobril-10mg-Tablet-SE-IS-MID"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100005188"/>
<resource>
<Organization>
<id value="LOC-100005188"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_LOC-100005188"> </a><p class="res-header-id"><b>Generated Narrative: Organization LOC-100005188</b></p><a name="LOC-100005188"> </a><a name="hcLOC-100005188"> </a><a name="hcLOC-100005188-en-US"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100005188</p><p><b>name</b>: Pfizer AB</p></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/v1/locations"/>
<value value="LOC-100005188"/>
</identifier>
<name value="Pfizer AB"/>
</Organization>
</resource>
</entry>
</Bundle>
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
